Your browser does not support JavaScript!
謝世良教授 Hsieh, Shie-Liang

特聘研究員 / 中央研究院基因體研究中心


[ CV ]
  • Email:
  • Tel: (02) 27871245



    • M.D., National Yang-Ming University, 1984
    • D.Phil., University of Oxford, UK, 1992
    • Postdoctoral fellow, Stanford University, 1993
    • Director, Institute of Clinical Medicine, Natl. Yang-Ming Univ., Taipei, Taiwan, 2010-2013
    • Department head, Department of Microbiology and Immunology, Natl. Yang-Ming Univ., Taipei, Taiwan, 2007-2013
    • Director, Immunology Research Center, Taipei Veterans’ General Hospital, Taiwan, 2005-2013Director, Immunology Research Center, Natl. Yang-Ming Univ., Taiwan, 2000-2013
    • Adjunct Senior Investigator, National Health Research Center, Taipei, Taiwan, from 2004
    • Adjunct Professor, Institute of Clinical Medicine, Natl. Yang-Ming Univ., Taipei, Taiwan, from 2013
    • Adjunct research fellow, Taipei Veterans’ General Hospital from 2013
    • Distinguished Research Fellow, Academia Sinica, Taipei, Taiwan, from 2013


    • 1989 Oversea PhD studentship from the Ministry of Education, Taiwan P
    • 1989 Oversea Research Scholarship (ORS) from the University of Oxford P
    • 1992 Irvington Medial Foundation post-doctoral fellowship ‘Robert Wood Johnson Fellow P
    • 1999, 2003, 2010 Outstanding Researcher Award from the National Science Council P
    • Outstanding Alumni, National Yang-Ming University P
    • Outstanding research Achievement to National Health, “Ming-Ning Wang Memorial Foundation”, 2008 P
    • Tsungming Tu Award, Taiwan Medical Society, 2009 P
    • Long-Term Award from Acer Foundation, 2009 P
    • Academic Achievement Award, Ministry of Education, 2009 P
    • 2012 National Chair Professor Award, Ministry of Education P
    • 2013 TienTe Lee Award




    Hsieh_Shie-Liang_pic01Research in the Hsieh lab encompasses the identification of glycans-binding proteins critical for host-pathogen interaction and immunomodulation, and production of monoclonal antibodies as potential novel therapeutic agents for anti-inflammation. New technology to detect weak interaction between glycans and lectins is developed to identify lectins receptors recognizing intact icosahedral virions, microparticles, microorganisms, and various glycoconjugates. Antagonistic bi-specific mAbs, and recombinant fusion proteins are being developed for immunomodulation to control aseptic and non-aseptic inflammatory diseases. Functions of novel polymorphic C-type lectins located in ER, Golgi and endosomes are being investigated systemically to reveal their impacts in the establishment of inflammatory reactions and human diseases.





  • 瀏覽數  
    Voice Play